CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs
Sheppard Health Law
FEBRUARY 22, 2023
With respect to the Part D Rebate Program, CMS is also soliciting comments on (i) the extent to which CMS should consider rebatable drugs that are not covered under the Medicaid Drug Rebate Program, and (ii) penalties for manufacturers who fail to pay rebates. The thirty-day public comment period ends on March 11, 2023. 9, 2023). [2]
52 
Let's personalize your content